{"id":18011,"date":"2021-11-29T10:04:38","date_gmt":"2021-11-29T18:04:38","guid":{"rendered":"https:\/\/marketdepth.com\/?p=18011"},"modified":"2021-11-29T10:10:44","modified_gmt":"2021-11-29T18:10:44","slug":"moderna-cmo-states-potential-of-omicron-vaccine","status":"publish","type":"post","link":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/","title":{"rendered":"Moderna Chief Medical Officer States Potential of Omicron Vaccine"},"content":{"rendered":"\n

According to Moderna\u2019s (NASDAQ: MRNA)<\/strong> Chief Medical Officer Paul Burton, the company could create a vaccine against the new omicron coronavirus variant by 2022.<\/p>\n\n\n\n

\u201cWe should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the MRNA vaccines, Moderna platform is that we can move very fast.\u201d<\/p>Burton said on BBC\u2019s Andrew Marr Show.<\/cite><\/blockquote>\n\n\n\n

\u201cIf we have to make a brand new vaccine I think that\u2019s going to be early 2022 before that\u2019s really going to be available in large quantities,\u201d the Moderna chief added.<\/p>\n\n\n\n

Variant of Concern<\/h5>\n\n\n\n

The World Health Organization considers Omicron a \u201cvariant of concern,\u201d which means it is more contagious than other variants. Omicron has 30 mutations to the spike protein, which allows it to enter the body. Ultimately, officials have warned that the current Covid vaccines could prove not to be fully effective against the variant.<\/p>\n\n\n\n

Originated in South Africa<\/h5>\n\n\n\n

Omicron, which was first detected in South Africa, has already spread across various countries such as Israel and Belgium. The spread prompted travel restrictions in Europe, Asia, and North America, according to Insider\u2019s Aria Bendix.<\/p>\n\n\n\n

Testing Against Omicron<\/h5>\n\n\n\n

Moderna is testing its current vaccine against the Omicron variant.  <\/p>\n\n\n\n

“Since early 2021, Moderna has advanced a comprehensive strategy to anticipate new variants of concern,” the company said. “The company has repeatedly demonstrated the ability to advance new candidates to clinical testing in 60 to 90 days.”   <\/p>\n","protected":false},"excerpt":{"rendered":"According to Moderna\u2019s (NASDAQ: MRNA) Chief Medical Officer Paul Burton, the company could create a vaccine against the new omicron coronavirus variant by 2022. \u201cWe should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the MRNA vaccines, Moderna platform is that… View Article<\/a>","protected":false},"author":3,"featured_media":18012,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":0,"footnotes":""},"categories":[9,10,31,8,11,16],"tags":[],"acf":[],"yoast_head":"\nModerna Chief Medical Officer States Potential of Omicron Vaccine - MarketDepth<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Moderna Chief Medical Officer States Potential of Omicron Vaccine - MarketDepth\" \/>\n<meta property=\"og:description\" content=\"According to Moderna\u2019s (NASDAQ: MRNA) Chief Medical Officer Paul Burton, the company could create a vaccine against the new omicron coronavirus variant by 2022. \u201cWe should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the MRNA vaccines, Moderna platform is that... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"MarketDepth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/marketdepthnews\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-29T18:04:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-29T18:10:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/11\/ModernaCovid19Vaccine.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MarketDepth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:site\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MarketDepth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/\"},\"author\":{\"name\":\"MarketDepth\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\"},\"headline\":\"Moderna Chief Medical Officer States Potential of Omicron Vaccine\",\"datePublished\":\"2021-11-29T18:04:38+00:00\",\"dateModified\":\"2021-11-29T18:10:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/\"},\"wordCount\":256,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"articleSection\":[\"Biotechnology\",\"Breaking\",\"Business\",\"Healthcare\",\"Investing\",\"What's Hot\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/\",\"url\":\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/\",\"name\":\"Moderna Chief Medical Officer States Potential of Omicron Vaccine - MarketDepth\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/#website\"},\"datePublished\":\"2021-11-29T18:04:38+00:00\",\"dateModified\":\"2021-11-29T18:10:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/marketdepth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Moderna Chief Medical Officer States Potential of Omicron Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/marketdepth.com\/#website\",\"url\":\"https:\/\/marketdepth.com\/\",\"name\":\"MarketDepth\",\"description\":\"Stock Market News & Headlines\",\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/marketdepth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/marketdepth.com\/#organization\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"contentUrl\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"MarketDepth\"},\"image\":{\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/marketdepthnews\",\"https:\/\/twitter.com\/MarketDepthNews\",\"https:\/\/www.instagram.com\/marketdepth\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/author\/3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Moderna Chief Medical Officer States Potential of Omicron Vaccine - MarketDepth","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"Moderna Chief Medical Officer States Potential of Omicron Vaccine - MarketDepth","og_description":"According to Moderna\u2019s (NASDAQ: MRNA) Chief Medical Officer Paul Burton, the company could create a vaccine against the new omicron coronavirus variant by 2022. \u201cWe should know about the ability of the current vaccine to provide protection in the next couple of weeks, but the remarkable thing about the MRNA vaccines, Moderna platform is that... View Article","og_url":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/","og_site_name":"MarketDepth","article_publisher":"https:\/\/www.facebook.com\/marketdepthnews","article_published_time":"2021-11-29T18:04:38+00:00","article_modified_time":"2021-11-29T18:10:44+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/11\/ModernaCovid19Vaccine.jpg","type":"image\/jpeg"}],"author":"MarketDepth","twitter_card":"summary_large_image","twitter_creator":"@MarketDepthNews","twitter_site":"@MarketDepthNews","twitter_misc":{"Written by":"MarketDepth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#article","isPartOf":{"@id":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/"},"author":{"name":"MarketDepth","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69"},"headline":"Moderna Chief Medical Officer States Potential of Omicron Vaccine","datePublished":"2021-11-29T18:04:38+00:00","dateModified":"2021-11-29T18:10:44+00:00","mainEntityOfPage":{"@id":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/"},"wordCount":256,"commentCount":0,"publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"articleSection":["Biotechnology","Breaking","Business","Healthcare","Investing","What's Hot"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/","url":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/","name":"Moderna Chief Medical Officer States Potential of Omicron Vaccine - MarketDepth","isPartOf":{"@id":"https:\/\/marketdepth.com\/#website"},"datePublished":"2021-11-29T18:04:38+00:00","dateModified":"2021-11-29T18:10:44+00:00","breadcrumb":{"@id":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/marketdepth.com\/moderna-cmo-states-potential-of-omicron-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/marketdepth.com\/"},{"@type":"ListItem","position":2,"name":"Moderna Chief Medical Officer States Potential of Omicron Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/marketdepth.com\/#website","url":"https:\/\/marketdepth.com\/","name":"MarketDepth","description":"Stock Market News & Headlines","publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/marketdepth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/marketdepth.com\/#organization","name":"MarketDepth","url":"https:\/\/marketdepth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/","url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","contentUrl":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","width":1500,"height":1000,"caption":"MarketDepth"},"image":{"@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/marketdepthnews","https:\/\/twitter.com\/MarketDepthNews","https:\/\/www.instagram.com\/marketdepth\/"]},{"@type":"Person","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69","name":"MarketDepth","url":"https:\/\/marketdepth.com\/author\/3\/"}]}},"_links":{"self":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18011"}],"collection":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/comments?post=18011"}],"version-history":[{"count":2,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18011\/revisions"}],"predecessor-version":[{"id":18017,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/18011\/revisions\/18017"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media\/18012"}],"wp:attachment":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media?parent=18011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/categories?post=18011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/tags?post=18011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}